Innovative Partnership Seeks Rapid Cure to Reduce TB Treatment Time from Six Months to One Month
NEW YORK–(ENEWSPF)–June 26, 2012 — Seven pharmaceutical companies and four research institutions including Weill Cornell Medical College, working with the Bill & Melinda Gates Foundation, have launched an innovative partnership that aims to speed the discovery of essential new treatments for tuberculosis (TB).
The partnership, known as the TB Drug Accelerator (TBDA), will target the discovery of new TB…
